Status:

COMPLETED

Improving Cardiovascular Health in Patients With Chronic Obstructive Pulmonary Disease

Lead Sponsor:

Virginia Commonwealth University

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

21+ years

Phase:

EARLY_PHASE1

Brief Summary

Researchers have found a link between chronic obstructive pulmonary disease (COPD) and heart disease; however, a link is all they have found. Cardiovascular health in COPD is controlled by different m...

Detailed Description

The present study is designed as a double-blind, randomized, cross-over, placebo-controlled protocol. Patients with COPD will receive either resveratrol (500 mg) or placebo for 12 weeks. A comprehensi...

Eligibility Criteria

Inclusion

  • Participants with a clinical diagnosis of COPD known for at least one year will be allowed to participate
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages II to IV
  • Breathing test ratio (FEV1/FVC) \<0.7
  • Amount of exhaled air (FEV1) \<80% predicted after bronchodilator
  • Total Lung Capacity (TLC)\>80%
  • Matched healthy volunteers without COPD.

Exclusion

  • FEV1/FVC\>0.7
  • Clinical diagnosis of heart disease, hypertension or diabetes
  • Use of vasoactive medications (nitrates, Beta blockers)
  • Uncontrolled high blood pressure
  • Pulmonary hypertension
  • Fluid in the lungs
  • Sleep apnea
  • Thyroid problems
  • Anemia
  • Raynaud's phenomenon
  • Gastrointestinal bleeding
  • History of coagulopathies
  • History of low platelets
  • Gangrene of the digits
  • Phenylketonuria
  • Pregnant or women attempting to become pregnant
  • In lactation
  • Individuals who may not be able to read or understand the resveratrol label

Key Trial Info

Start Date :

July 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 30 2023

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT03819517

Start Date

July 1 2019

End Date

August 30 2023

Last Update

April 29 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Virginia Commonwealth University

Richmond, Virginia, United States, 23298